| [1] |
Ren X, Dong Y, Duan M, et al. Abnormal expression of HNRNPA3 in multistep hepatocarcinogenesis[J]. Oncol Lett, 2021, 21:46. doi: 10.3892/ol.2020.12307.
|
| [2] |
Fateen W, Johnson PJ, Wood HM, et al. Characterisation of dysplastic liver nodules using low-pass DNA sequencing and detection of chromosome arm-level abnormalities in blood-derived cell-free DNA[J]. J Pathol, 2021, 255:30-40.
|
| [3] |
De Nunzio V, Carrieri L, Scavo MP, et al. Plasma-derived exosomes from NAFLD patients modulate the cannabinoid receptors′ expression in cultured HepaRG cells[J]. Int J Mol Sci, 2023, 24:1739. doi: 10.3390/ijms24021739.
|
| [4] |
Tong L, Yan C, Wang M, et al. Prognostic value of serum exosomal AHCY expression in hepatitis B-induced liver cirrhosis[J]. Front Med (Lausanne), 2021, 8:777452. doi: 10.3389/fmed.2021.777452.
|
| [5] |
Sanchez JI, Jiao J, Kwan SY, et al. Lipidomic profiles of plasma exosomes identify candidate biomarkers for early detection of hepatocellular carcinoma in patients with cirrhosis[J]. Cancer Prev Res (Phila), 2021, 14:955-962.
|
| [6] |
Wu B, Feng J, Guo J, et al. ADSCs-derived exosomes ameliorate hepatic fibrosis by suppressing stellate cell activation and remodeling hepatocellular glutamine synthetase-mediated glutamine and ammonia homeostasis[J]. Stem Cell Res Ther, 2022, 13:494. doi: 10.1186/s13287-022-03049-x.
|
| [7] |
Koksal AR, Thevenot P, Aydin Y, et al. Impaired autophagy response in hepatocellular carcinomas enriches glypican-3 in exosomes, not in the microvesicles[J]. J Hepatocell Carcinoma, 2022, 9:959-972.
|
| [8] |
Aydin Y, Koksal AR, Thevenot P, et al. Experimental validation of novel glypican 3 exosomes for the detection of hepatocellular carcinoma in liver cirrhosis[J]. J Hepatocell Carcinoma, 2021, 8:1579-1596.
|
| [9] |
Lee J, Jeong I, Kim OK. Liver-derived exosomes induce inflammation and lipogenesis in mice fed high-energy diets[J]. Nutrients, 2022, 14:5124. doi: 10.3390/nu14235124.
|
| [10] |
Zhang Z, Shang J, Yang Q, et al. Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K/Akt/mTOR pathway and remodeling choline metabolism[J]. J Nanobiotechnology, 2023, 21:29. doi: 10.1186/s12951-023-01788-4.
|
| [11] |
Chen L, Huang Y, Duan Z, et al. Exosomal miR-500 derived from lipopolysaccharide-treated macrophage accele-rates liver fibrosis by suppressing MFN2[J]. Front Cell Dev Biol, 2021, 9:716209. doi: 10.3389/fcell.2021.716209.
|
| [12] |
Kim HY, Min HK, Song HW, et al. Delivery of human natural killer cell-derived exosomes for liver cancer therapy: an in vivo study in subcutaneous and orthotopic animal models[J]. Drug Deliv, 2022, 29:2897-2911.
|
| [13] |
Li Z, Zhao P, Zhang Y, et al. Exosome-based ldlr gene therapy for familial hypercholesterolemia in a mouse model[J]. Theranostics, 2021, 11:2953-2965.
|
| [14] |
Zhang Q, Qu Y, Zhang Q, et al. Exosomes derived from hepatitis B virus-infected hepatocytes promote liver fibrosis via miR-222/TFRC axis[J]. Cell Biol Toxicol, 2022,: 1-15.
|
| [15] |
Zhang Y, Zhangdi H, Nie X, et al. Exosomes derived from BMMSCs mitigate the hepatic fibrosis via anti-pyroptosis pathway in a cirrhosis model[J]. Cells, 2022, 11:4004. doi: 10.3390/cells11244004.
|
| [16] |
Hasanin AH, Matboli M, Seleem HS. Hesperidin suppressed hepatic precancerous lesions via modulation of exophagy in rats[J]. J Cell Biochem, 2020, 121: 1295-1306.
|
| [17] |
Dai X, Chen C, Yang Q, et al. Exosomal circRNA_100284 from arsenite-transformed cells, via microRNA-217 regulation of EZH2, is involved in the malignant transformation of human hepatic cells by accelerating the cell cycle and promoting cell proliferation[J]. Cell Death Dis, 2018, 9: 454-467.
|
| [18] |
Fründt T, Krause L, Hussey E, et al. Diagnostic and prognostic value of miR-16, miR-146a, miR-192 and miR-221 in exosomes of hepatocellular carcinoma and liver cirrhosis patients[J]. Cancers (Basel), 2021, 13: 2484.doi:10.3390/cancers13102484.
|
| [19] |
Lin Y, Dong MQ, Liu ZM, et al. A strategy of vascular-targeted therapy for liver fibrosis[J]. Hepatology, 2022, 76:660-675.
|
| [20] |
Witek RP, Yang L, Liu R, et al. Liver cell-derived microparticles activate hedgehog signaling and alter gene expression in hepatic endothelial cells[J]. Gastroenterology, 2009, 136:320-330.
|
| [21] |
Wei H, Xu Z, Chen L, et al. Long non-coding RNA PAARH promotes hepatocellular carcinoma progression and angiogenesis via upregulating HOTTIP and activating HIF-1α/VEGF signaling[J]. Cell Death Dis, 2022, 13:102. doi: 10.1038/s41419-022-04505-5.
|
| [22] |
Han L, Lin X, Yan Q, et al. PBLD inhibits angiogenesis via impeding VEGF/VEGFR2-mediated microenvironmental cross-talk between HCC cells and endothelial cells[J]. Oncogene, 2022, 41:1851-1865.
|
| [23] |
Chen QL, Xie CF, Feng KL, et al. microRNAs carried by exosomes promote epithelial-mesenchymal transition and metastasis of liver cancer cells[J]. Am J Transl Res, 2020, 12:6811-6826.
|
| [24] |
Xie CF, Feng KL, Wang JN, et al. Jianpi huayu decoction inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling[J]. J Ethnopharmacol, 2022, 294:115360. doi: 10.1016/j.jep.2022.115360.
|
| [25] |
Benbow JH, Marrero E, McGee RM, et al. Hepatic stellate cell-derived exosomes modulate macrophage inflammatory response[J]. Exp Cell Res, 2021, 405: 112663-112672.
|
